Search Results

There are 3817 results for: content related to: The effect of deprenyl and levodopa on the progression of Parkinson's disease

  1. Deprenyl (selegiline): the history of its development and pharmacological action

    Acta Neurologica Scandinavica

    Volume 68, Issue s95, July 1983, Pages: 57–80, J. KNOLL

    Version of Record online : 29 JAN 2009, DOI: 10.1111/j.1600-0404.1983.tb01517.x

  2. (–)Deprenyl-Medication: A Strategy To Modulate the Age-Related Decline of the Striatal Dopaminergic System

    Journal of the American Geriatrics Society

    Volume 40, Issue 8, August 1992, Pages: 839–847, József Knoll

    Version of Record online : 27 APR 2015, DOI: 10.1111/j.1532-5415.1992.tb01860.x

  3. You have free access to this content
    (-)Deprenyl (Selegiline), a Catecholaminergic Activity Enhancer (CAE) Substance Acting in the Brain

    Pharmacology & Toxicology

    Volume 82, Issue 2, February 1998, Pages: 57–66, Joseph Knull

    Version of Record online : 25 MAR 2009, DOI: 10.1111/j.1600-0773.1998.tb01399.x

  4. You have free access to this content
    Antiaging Compounds: (-)Deprenyl (Selegiline) and (-)1-(Benzofuran-2-yl)-2-propylaminopentane, [(-)BPAP], a Selective Highly Potent Enhancer of the Impulse Propagation Mediated Release of Catecholamines and Serotonin in the Brain

    CNS Drug Reviews

    Volume 7, Issue 3, September 2001, Pages: 317–345, J. Knoll

    Version of Record online : 7 JUN 2006, DOI: 10.1111/j.1527-3458.2001.tb00202.x

  5. Pharmacological basis of the therapeutic effect of (−)deprenyl in age-related neurological diseases

    Medicinal Research Reviews

    Volume 12, Issue 5, September 1992, Pages: 505–524, Jozsef Knoll

    Version of Record online : 18 SEP 2006, DOI: 10.1002/med.2610120504

  6. Mortality in DATATOP: A Multicenter trial in early Parkinson's disease

    Annals of Neurology

    Volume 43, Issue 3, March 1998, Pages: 318–325, Dr Shoulson

    Version of Record online : 8 OCT 2004, DOI: 10.1002/ana.410430309

  7. The pharmacology of selegiline ((−)deprenyl). New aspects

    Acta Neurologica Scandinavica

    Volume 80, Issue s126, November 1989, Pages: 83–91, J. Knoll

    Version of Record online : 29 JAN 2009, DOI: 10.1111/j.1600-0404.1989.tb01787.x

  8. Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP subjects not requiring levodopa

    Annals of Neurology

    Volume 39, Issue 1, January 1996, Pages: 29–36,

    Version of Record online : 8 OCT 2004, DOI: 10.1002/ana.410390106

  9. Suppression of Hydroxyl Radical Formation and Protection of Nigral Neurons by l-Deprenyl (Selegiline)

    Annals of the New York Academy of Sciences

    Volume 786, Issue 1, June 1996, Pages: 379–390, RUEY-MEEI WU, DENNIS L. MURPHY and CHUANG C. CHIUEH

    Version of Record online : 17 DEC 2006, DOI: 10.1111/j.1749-6632.1996.tb39078.x

  10. The Pharmacological Profile of (–)Deprenyl (Selegiline) and its Relevance for Humans: A Personal View

    Pharmacology & Toxicology

    Volume 70, Issue 5, May 1992, Pages: 317–321, J. Knoll

    Version of Record online : 25 MAR 2009, DOI: 10.1111/j.1600-0773.1992.tb00480.x

  11. Therapy with l-deprenyl (selegiline) and relation to abuse liability

    Clinical Pharmacology & Therapeutics

    Volume 56, Issue S6, December 1994, Pages: 750–756, Lon S Schneider, Pierre N Tariot and Bonnie Goldstein

    Version of Record online : 19 DEC 1994, DOI: 10.1038/clpt.1994.205

  12. Slow recovery of human brain MAO B after L-Deprenyl (Selegeline) withdrawal

    Synapse

    Volume 18, Issue 2, October 1994, Pages: 86–93, Joanna S. Fowler, Nora D. Volkow, Jean Logan, Gene-Jack Wang, Robert R. Mac Gregor, David Schlyer, Alfred P. Wolf, Naomi Pappas, David Alexoff, Colleen Shea, Ernest Dorflinger, Lesia Kruchowy, Kisook Yoo, Enrico Fazzini and Clifford Patlak

    Version of Record online : 12 OCT 2004, DOI: 10.1002/syn.890180203

  13. You have free access to this content
    l-Deprenyl Protects Mesencephalic Dopamine Neurons from Glutamate Receptor-Mediated Toxicity In Vitro

    Journal of Neurochemistry

    Volume 68, Issue 1, January 1997, Pages: 33–39, Catherine Mytilineou, Pheona Radcliffe, Efthimia Kokotos Leonardi, Peter Werner and C. Warren Olanow

    Version of Record online : 18 NOV 2002, DOI: 10.1046/j.1471-4159.1997.68010033.x

  14. DATATOP: A decade of neuroprotective inquiry

    Annals of Neurology

    Volume 44, Issue S1, September 1998, Pages: S160–S166, Dr Ira Shoulson and Parkinson Study Group

    Version of Record online : 21 FEB 2014, DOI: 10.1002/ana.410440724

  15. Effect of Long-Term Treatment with Selective Monoamine Oxidase A and B Inhibitors on Dopamine Release from Rat Striatum In Vivo

    Journal of Neurochemistry

    Volume 67, Issue 4, October 1996, Pages: 1532–1539, Itschak Lamensdorf, Moussa B. H. Youdim and John P. M. Finberg

    Version of Record online : 23 NOV 2002, DOI: 10.1046/j.1471-4159.1996.67041532.x

  16. You have free access to this content
    Tyramine-induced noradrenaline release from rat brain slices: prevention by (-)-deprenyl

    British Journal of Pharmacology

    Volume 80, Issue 1, September 1983, Pages: 141–148, Vivette Glover, C.J. Pycock and M. Sandler

    Version of Record online : 19 JUL 2012, DOI: 10.1111/j.1476-5381.1983.tb11059.x

  17. You have free access to this content
    R-Deprenyl and R-2-Heptyl-N-Methylpropargylamine Prevent Apoptosis in Cerebellar Granule Neurons Induced by Cytosine Arabinoside but Not Low Extracellular Potassium

    Journal of Neurochemistry

    Volume 70, Issue 2, February 1998, Pages: 515–523, I. A. Paterson, D. Zhang, R. C. Warrington and A. A. Boulton

    Version of Record online : 14 NOV 2002, DOI: 10.1046/j.1471-4159.1998.70020515.x

  18. Chiral characterization of deprenyl-N-oxide and other deprenyl metabolites by capillary electrophoresis using a dual cyclodextrin system in rat urine

    ELECTROPHORESIS

    Volume 24, Issue 15, No. 15 August 2003, Pages: 2665–2673, Tamás Tábi, Kálmán Magyar and Éva Szökő

    Version of Record online : 31 JUL 2003, DOI: 10.1002/elps.200305468

  19. Pharmacological Interventions in Aging and Age-associated Disorders

    Annals of the New York Academy of Sciences

    Volume 959, Issue 1, April 2002, Pages: 295–307, KENICHI KITANI, CHIYOKO MINAMI, TAKAKO YAMAMOTO, SETSUKO KANAI, GWEN O. IVY and MARIA-CRISTINA CARRILLO

    Version of Record online : 24 JAN 2006, DOI: 10.1111/j.1749-6632.2002.tb02101.x

  20. Intravenous self-administration studies with l-deprenyl (selegiline) in monkeys

    Clinical Pharmacology & Therapeutics

    Volume 56, Issue S6, December 1994, Pages: 774–780, Gail D Winger, Sevil Yasar, S Steven Negus and Steven R Goldberg

    Version of Record online : 19 DEC 1994, DOI: 10.1038/clpt.1994.208